Category: neuroendocrine tumors

Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community

The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100  abstracts on carcinoid…

6 iPhone, Droid, BlackBerry, and iPad Apps for Carcinoid Patients and Physicians

A new iPhone app from ASCO, an app from 3M for physicians to help them manage and keep track of patient data, and the American Cancer Society’s Journals app are some of the newest mobile apps in the areas of medicine and healthcare.  For carcinoid and neuroendocrine…

Breaking News: FDA Approves Treatment for pNET Patients

For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients!  The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients.  This is a milestone for the carcinoid/NET…

All Things Zebra for Carcinoid and Neuroendocrine Tumor Awareness

At the Carcinoid Cancer Foundation we get many inquiries about where to purchase zebra-striped pins and other awareness items.  We have scoured the Internet to share a wide variety of jewelry, party supplies, note cards, luggage, organizers, and everyday…

1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)

Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …

Multiple Endocrine Neoplasia (MEN) Seminar Scheduled for September 2011 at Mayo Clinic

SPECIAL NOTE:  This seminar has been cancelled but may be rescheduled at a later date in a different format.  We will post any updates we  receive.

__________________________________________________________________

MEN, carcinoid, and neuroendocrine…

RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients

Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund.  According to Ebrahim…

Carcinoid Cancer Foundation Symposium Features Leading NET Cancer Specialists & a Patient Panel

What are the most state-of-the-art treatments for carcinoid and NET cancer patients today?  Join us on May 1st when the Carcinoid Cancer Foundation presents its 14th Annual Symposium, “Neuroendocrine Tumor Management: The Era of Personalized…

Neuroendocrine Tumors Featured on Healthy Body, Healthy Mind Television Series

For a comprehensive overview of neuroendocrine tumors, watch this fascinating video on the Healthy Body, Healthy Mind television series. Every episode on the health and wellness TV series focuses on the stories of real people; people who are working…

Carcinoid Cancer Foundation Asks You to Help Support Rare Disease Day: Write Your Reps Campaign

Carcinoid patients, physicians, family, friends and colleagues can help support Rare Disease Day 2011 by participating in NORD’s Write Your Reps Campaign.  NORD (National Organization for Rare Diseases) and its advocacy partners have worked with…